tirzepatide sleep apnea trial Lilly's weight-loss drug reduces severity in late-stage trials Weight Loss and Sleep Apnea

Circana data indicates that households indexed higher on active shorts, casual pants, jeans, bras, and dresses during their first year of GLP1 use, compared to before treatment began

These effects are dose-dependent and typically mild at the starting dose

The drugs have shown remarkable efficacy in treating obesity in addition to their utility in controlling Type 2 diabetes

Analysts note that the partnership underscores how retailers are adapting pharmacy strategies to capitalize on the GLP-1 boom positioning themselves not only as access points for prescriptions but as central players in the broader health and wellness economy.

The factor V Leiden variant is found in about 5-8% of people of European descent